About
Hunter Davis Ozawa is the CSO and co-founder of Until Labs, a company developing reversible cryopreservation technology for organs with longer-term implications for medical hibernation and longevity. In Until's 2024 founder letter, he describes a personal motivation rooted in the loss of his father-in-law and frames his work around pausing biological time to expand treatment options. Public reports from ATP-Bio also place him in the cryobiology ecosystem as an IAB board member and identify him as Head of Science at Heisenberg Inc.; a Harvard-assigned patent listing further supports his technical/inventor background.
Areas of interest
longevitybiotechcryopreservationorgan transplantationbiopreservationneurosciencechemistryphysicsmaterials sciencemolecular biology